Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention

Published:2014-09 Issue:9 Volume:64 Page:863-871
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Mayer Katharina,Bernlochner Isabell,Braun Siegmund,Schulz Stefanie,Orban Martin,Morath Tanja,Cala Lisena,Hoppmann Petra,Schunkert Heribert,Laugwitz Karl-Ludwig,Kastrati Adnan,Sibbing Dirk

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding;Tantry;J Am Coll Cardiol,2013

2. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease;Gum;J Am Coll Cardiol,2003

3. High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention;Breet;Heart,2011

4. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization;Frelinger;Circulation,2009

5. Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study;Christiaens;Blood Coagul Fibrinolysis,2008

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease Patients;International Journal of Molecular Sciences;2024-08-09

2. Antiplatelet Resistance in Coronary Artery Bypass Grafting: A Systematic Review;Surgery Research and Practice;2024-01

3. Editorial: The individualization of antiplatelet therapy in coronary artery disease: escalation or de-escalations;Frontiers in Cardiovascular Medicine;2023-06-06

4. Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome;Journal of Clinical Medicine;2023-02-17

5. High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry;Clinical Research in Cardiology;2023-02-14